FEDERATED HERMES, INC.

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA

Position in FDMT

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,958,132

-$10,376,208 QoQ

Shares Held

222,416

-84.5% QoQ

Ownership

0.308%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 158 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. FDMT ranks #79 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,958,132	222,416	-84.5%	Shares	Defined	2026-08-12
2026-03-31	$13,334,340	1,432,260	-11.0%	Shares	Defined	2026-05-11
2025-12-31	$12,071,114	1,609,482	+0.9%	Shares	Defined	2026-02-12
2025-09-30	$13,859,089	1,594,832	-4.3%	Shares	Defined	2025-11-03
2025-06-30	$6,185,823	1,667,338	+33.4%	Shares	Defined	2025-08-13
2025-03-31	$4,038,084	1,250,181	+33131.8%	Shares	Defined	2025-05-08
2024-12-31	$20,954	3,762	+13833.3%	Shares	Defined	2025-02-13
2024-03-31	$860	27	-87.7%	Shares	Defined	2024-05-14
2022-06-30	$1,528	219	-94.8%	Shares	Defined	2022-09-16
2021-06-30	$101,136	4,200	-97.2%	Shares	Defined	2021-08-16
2021-03-31	$6,507,000	150,000	0.0%	Shares	Defined	2021-05-13
2020-12-31	$6,217,500	150,000	—	Shares	Defined	2021-02-12
No filing history on record for this holder in this stock.